手法を比較

	ALS機能評価尺度改訂版 (ALSFRS-R)	多発性硬化症歩行スケール-12 (MSWS-12)
分野	神経学	神経学
系統	Process / pipeline	Process / pipeline
提唱年	1999	2003
提唱者	James M. Cedarbaum, NIH/NINDS	Jeremy C. Hobart, University of Plymouth
種類	Clinician-rated and patient-reported hybrid	Self-report questionnaire
原典	Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999). The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. Journal of the Neurological Sciences, 169(1-2), 13-21.	Hobart, J. C., Riazi, A., Lamping, D. L., Fitzpatrick, R., & Thompson, A. J. (2003). Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12). Neurology, 60(1), 31-36.
別名	ALS FRS-R, Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised	MS Walking Scale-12, MSWS
関連	4	3
概要	The ALSFRS-R is a 12-item clinician-administered functional rating scale designed to assess disease progression and functional status in amyotrophic lateral sclerosis (ALS). Introduced by Cedarbaum and colleagues in 1999, it expands upon the original ALSFRS by incorporating respiratory function assessment. It is the primary outcome measure in ALS clinical trials and routine clinical monitoring, providing quantitative tracking of disease decline that predicts survival and guides management decisions.	The MSWS-12 is a brief, patient-reported outcome measure specifically designed to assess the impact of multiple sclerosis on walking ability and limitation. Developed by Hobart and colleagues in 2003, this 12-item scale captures both the physical difficulty and functional consequences of MS-related gait impairment. It is highly responsive to change and widely used in MS clinical trials and practice as a primary outcome measure for assessing intervention effects on mobility.